CVS Health Co. (NYSE:CVS - Free Report) - Analysts at Leerink Partnrs decreased their Q4 2024 EPS estimates for CVS Health in a research note issued on Wednesday, December 18th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will post earnings per share of $0.98 for the quarter, down from their prior estimate of $1.24. The consensus estimate for CVS Health's current full-year earnings is $5.32 per share. Leerink Partnrs also issued estimates for CVS Health's Q2 2025 earnings at $1.66 EPS.
CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. During the same period last year, the company earned $2.21 earnings per share. The business's revenue was up 6.3% on a year-over-year basis.
CVS has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective for the company in a research note on Tuesday, December 3rd. StockNews.com cut CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Truist Financial reaffirmed a "buy" rating and set a $67.00 target price (down previously from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Piper Sandler cut their price objective on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating for the company in a research report on Monday, November 25th. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $69.12.
View Our Latest Stock Report on CVS Health
CVS Health Stock Performance
CVS stock traded down $0.22 during mid-day trading on Monday, hitting $44.14. The company had a trading volume of 16,401,068 shares, compared to its average volume of 11,674,143. CVS Health has a 12 month low of $43.56 and a 12 month high of $83.25. The stock's fifty day moving average price is $56.24 and its two-hundred day moving average price is $58.21. The firm has a market cap of $55.55 billion, a PE ratio of 11.20, a price-to-earnings-growth ratio of 0.85 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. Garland Capital Management Inc. raised its stake in shares of CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock valued at $3,591,000 after buying an additional 160 shares during the last quarter. Sound Income Strategies LLC lifted its holdings in CVS Health by 7.2% in the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after acquiring an additional 162 shares during the period. Hexagon Capital Partners LLC boosted its position in CVS Health by 3.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock worth $331,000 after purchasing an additional 178 shares in the last quarter. Bruce G. Allen Investments LLC grew its stake in shares of CVS Health by 13.1% during the 3rd quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator's stock worth $106,000 after purchasing an additional 195 shares during the period. Finally, HHM Wealth Advisors LLC lifted its stake in shares of CVS Health by 11.9% in the 2nd quarter. HHM Wealth Advisors LLC now owns 1,886 shares of the pharmacy operator's stock valued at $111,000 after purchasing an additional 200 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.
About CVS Health
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
